Comparison of the Effects of Melatonin and Oxazepam on Anxiety Levels and Sleep Quality in Patients With ST-Segment-Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention: A Randomized Clinical Trial.
Padideh GhaeliMohammad SolduzianShaghayegh VejdaniAzita Hajhossein TalasazPublished in: The Annals of pharmacotherapy (2018)
The results of this study suggest that melatonin, a drug with more favorable drug interaction and adverse effect profile, could be more effective than oxazepam in improving the sleep quality and anxiety levels of patients presenting with STEMI, and it could be considered a new alternative to benzodiazepines in this setting.
Keyphrases
- sleep quality
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- depressive symptoms
- st elevation myocardial infarction
- acute coronary syndrome
- acute myocardial infarction
- coronary artery disease
- antiplatelet therapy
- coronary artery bypass grafting
- physical activity
- adverse drug
- coronary artery bypass
- atrial fibrillation
- emergency department
- left ventricular